Registration in Brazil

In Brazil, the regulatory agency responsible for pharmaceuticals and healthcare products is the Agência Nacional de Vigilância Sanitária (ANVISA). To register a product in Brazil, the following steps are typically involved:

1. Pre-submission Assessment: Prior to registration, it’s advisable to conduct a pre-submission assessment to understand the regulatory requirements and ensure that the product complies with local standards.
2. Dossier Preparation: A comprehensive dossier, including data on product safety, efficacy, quality, and manufacturing, must be prepared. This dossier often needs to align with ANVISA’s specific requirements.
3. Submission: The product registration application is submitted to ANVISA, and the review process begins. This process includes a thorough evaluation of the dossier and may involve queries and requests for additional information.
4. Clinical Trials: If required, clinical trials must be conducted in Brazil, and their results should be submitted for evaluation.
5. Inspection: ANVISA may conduct inspections of manufacturing facilities to ensure compliance with good manufacturing practices (GMP).
6. Approval: Once ANVISA is satisfied with the data and inspections, product registration is granted.